Literature DB >> 26191310

Reactive lymphoid hyperplasia of the liver mimicking hepatocellular carcinoma: incidental finding of two cases.

Ang Lv1, Wendy Liu2, Hong-Gang Qian1, Jia-Hua Leng1, Chun-Yi Hao1.   

Abstract

Reactive lymphoid hyperplasia is a rare disease that forms a mass-like lesion and is characterized by the proliferation of non-neoplastic, polyclonal lymphocytes forming follicles. We recently encountered 2 cases of reactive lymphoid hyperplasia of liver, both of which were asymptomatic and mimicked hepatocellular carcinoma by various imaging modalities. Based on the clinical impression of hepatocellular carcinoma, surgical resections were performed. Microscopic findings revealed that both lesions consisted of an aggregation of lymphocytes consisting of predominantly B-cells, with multiple lymphoid follicles positive for CD10 and negative for bcl-2, consistent with the diagnosis of reactive lymphoid hyperplasia. Polyclonality of both lesions was further confirmed by B cell receptor gene rearrangement study. The incidence of reactive lymphoid hyperplasia in the liver is exceedingly rare, and it is difficult to differentiate such lesions from hepatic malignancies based upon clinical grounds. The clinicopathological findings and literature review of this report may be helpful to improve the clinical decision-making.

Entities:  

Keywords:  Reactive lymphoid hyperplasia; hepatocellular carcinoma; liver

Mesh:

Substances:

Year:  2015        PMID: 26191310      PMCID: PMC4503181     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  17 in total

1.  An operative case of hepatic pseudolymphoma difficult to differentiate from primary hepatic marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.

Authors:  Michihiro Hayashi; Noboru Yonetani; Fumitoshi Hirokawa; Mitsuhiro Asakuma; Katsuhiko Miyaji; Atsushi Takeshita; Kazuhiro Yamamoto; Hironori Haga; Takayuki Takubo; Nobuhiko Tanigawa
Journal:  World J Surg Oncol       Date:  2011-01-13       Impact factor: 2.754

Review 2.  A case of pseudolymphoma of the liver with chronic hepatitis C.

Authors:  S R Kim; Y Hayashi; K B Kang; C G Soe; J H Kim; M K Yang; H Itoh
Journal:  J Hepatol       Date:  1997-01       Impact factor: 25.083

3.  Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma?

Authors:  Masatoshi Kudo
Journal:  Oncology       Date:  2010-07-08       Impact factor: 2.935

4.  Gastric "pseudolymphoma": a retrospective morphologic and immunophenotypic study of 97 cases.

Authors:  S L Abbondanzo; L H Sobin
Journal:  Cancer       Date:  1997-05-01       Impact factor: 6.860

5.  Pseudolymphoma of the stomach. A clinicopathologic study of 15 cases.

Authors:  O Tokunaga; T Watanabe; M Morimatsu
Journal:  Cancer       Date:  1987-04-01       Impact factor: 6.860

6.  Development of pseudolymphoma of liver following interferon-alpha therapy for chronic hepatitis B.

Authors:  T Ohtsu; Y Sasaki; H Tanizaki; N Kawano; M Ryu; M Satake; T Hasebe; K Mukai; M Fujikura; M Tamai
Journal:  Intern Med       Date:  1994-01       Impact factor: 1.271

Review 7.  Hepatic pseudolymphoma: a clinicopathological study of five cases and review of the literature.

Authors:  Yoh Zen; Takahiko Fujii; Yasuni Nakanuma
Journal:  Mod Pathol       Date:  2009-11-13       Impact factor: 7.842

8.  'Pseudolymphoma'. A case associated with primary immunodeficiency disease and polyglandular failure syndrome.

Authors:  D C Snover; A H Filipovich; L P Dehner; W Krivit
Journal:  Arch Pathol Lab Med       Date:  1981-01       Impact factor: 5.534

9.  Reactive lymphoid hyperplasia of the liver in a patient with colon cancer: report of two cases.

Authors:  Hiroki Takahashi; Hirozumi Sawai; Yoichi Matsuo; Hitoshi Funahashi; Mikinori Satoh; Yuji Okada; Hiroshi Inagaki; Hiromitsu Takeyama; Tadao Manabe
Journal:  BMC Gastroenterol       Date:  2006-09-12       Impact factor: 3.067

10.  Reactive lymphoid hyperplasia of the liver.

Authors:  Woo Sung Moon; Keum Ha Choi
Journal:  Clin Mol Hepatol       Date:  2013-03
View more
  8 in total

1.  Pseudolymphoma (reactive lymphoid hyperplasia) of the liver: A clinical challenge.

Authors:  Yong Kyong Kwon; Reena C Jha; Kambiz Etesami; Thomas M Fishbein; Metin Ozdemirli; Chirag S Desai
Journal:  World J Hepatol       Date:  2015-11-18

2.  Hepatic Pseudolymphoma with Fluorodeoxyglucose Uptake on Positron Emission Tomography.

Authors:  Kazuhiro Suzumura; Etsuro Hatano; Toshihiro Okada; Yasukane Asano; Naoki Uyama; Seikan Hai; Ami Kurimoto; Kentaro Nonaka; Tohru Tsujimura; Jiro Fujimoto
Journal:  Case Rep Gastroenterol       Date:  2017-12-21

3.  Reactive lymphoid hyperplasia of the liver: A case report.

Authors:  Wenyan Zhang; Shusen Zheng
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

4.  A case of reactive lymphoid hyperplasia of the liver in a patient with autoimmune hepatitis.

Authors:  Hiroki Kanno; Hisamune Sakai; Toru Hisaka; Satoki Kojima; Ryuta Midorikawa; Shogo Fukutomi; Yoriko Nomura; Yuichi Goto; Toshihiro Sato; Munehiro Yoshitomi; Ryuichi Kawahara; Koji Okuda
Journal:  Surg Case Rep       Date:  2020-05-04

5.  Diffusion-weighted imaging might be useful for reactive lymphoid hyperplasia diagnosis of the liver: A case report.

Authors:  Taro Tanaka; Kazuhiro Saito; Daisuke Yunaiyama; Jun Matsubayashi; Yuichi Nagakawa; Maki Tanigawa; Toshitaka Nagao
Journal:  World J Clin Cases       Date:  2020-11-06       Impact factor: 1.337

Review 6.  FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.

Authors:  Kumi Ozaki; Kenichi Harada; Noboru Terayama; Nobuyuki Kosaka; Hirohiko Kimura; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2020-04-03       Impact factor: 2.374

7.  Intrahepatic Reactive Lymphoid Hyperplasia: A Case Report and Review of the Literature.

Authors:  Samantha Seitter; Zachary D Goodman; Theodore M Friedman; Timothy R Shaver; George Younan
Journal:  Case Rep Surg       Date:  2018-09-06

8.  Imaging Manifestations of Intrahepatic Reactive Lymphoid Hyperplasia: A Case Report and Literature Review.

Authors:  Bingqian Zhang; Mingyue Zou; Zengxin Lu; Haijia Mao; Ya'nan Huang; Fang Liu; Zhenhua Zhao
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.